LSE - Delayed Quote GBp

Beximco Pharmaceuticals Limited (BXP.L)

35.00
-1.00
(-2.78%)
At close: 3:02:04 PM GMT+1
Loading Chart for BXP.L
  • Previous Close 36.00
  • Open 34.71
  • Bid 34.00 x --
  • Ask 38.00 x --
  • Day's Range 34.71 - 34.71
  • 52 Week Range 19.33 - 41.00
  • Volume 37,004
  • Avg. Volume 31,256
  • Market Cap (intraday) 156.139M
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) 3.89
  • EPS (TTM) 0.09
  • Earnings Date May 14, 2025 - May 15, 2025
  • Forward Dividend & Yield 0.03 (7.27%)
  • Ex-Dividend Date Nov 25, 2024
  • 1y Target Est --

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

www.beximcopharma.com

6,000

Full Time Employees

June 30

Fiscal Year Ends

Recent News: BXP.L

View More

Performance Overview: BXP.L

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

BXP.L
10.26%
MSCI WORLD (^990100-USD-STRD)
3.32%

1-Year Return

BXP.L
14.55%
MSCI WORLD (^990100-USD-STRD)
11.52%

3-Year Return

BXP.L
56.42%
MSCI WORLD (^990100-USD-STRD)
41.82%

5-Year Return

BXP.L
6.96%
MSCI WORLD (^990100-USD-STRD)
91.55%

Compare To: BXP.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BXP.L

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    238.60M

  • Enterprise Value

    262.30M

  • Trailing P/E

    4.09

  • Forward P/E

    2.99

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    0.52

  • Enterprise Value/Revenue

    0.92

  • Enterprise Value/EBITDA

    3.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.71%

  • Return on Assets (ttm)

    7.62%

  • Return on Equity (ttm)

    12.45%

  • Revenue (ttm)

    46.34B

  • Net Income Avi to Common (ttm)

    6.35B

  • Diluted EPS (ttm)

    0.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.85B

  • Total Debt/Equity (mrq)

    11.55%

  • Levered Free Cash Flow (ttm)

    2.14B

Research Analysis: BXP.L

View More

People Also Watch